Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 41

1.

Hippocampal spatial position evaluation on MRI for research and clinical practice.

Mrzílkova J, Koutela A, Kutová M, Patzelt M, Ibrahim I, Al-Kayssi D, Bartoš A, Řípová D, Čermáková P, Zach P.

PLoS One. 2014 Dec 12;9(12):e115174. doi: 10.1371/journal.pone.0115174. eCollection 2014.

2.

A review of neuroimaging biomarkers of Alzheimer's disease.

Varghese T, Sheelakumari R, James JS, Mathuranath P.

Neurol Asia. 2013;18(3):239-248.

3.

Mapping ventricular expansion onto cortical gray matter in older adults.

Madsen SK, Gutman BA, Joshi SH, Toga AW, Jack CR Jr, Weiner MW, Thompson PM; Alzheimer's Disease Neuroimaging Initiative (ADNI).

Neurobiol Aging. 2015 Jan;36 Suppl 1:S32-41. doi: 10.1016/j.neurobiolaging.2014.03.044. Epub 2014 Aug 30.

4.

Brain imaging of mild cognitive impairment and Alzheimer's disease.

Yin C, Li S, Zhao W, Feng J.

Neural Regen Res. 2013 Feb 15;8(5):435-44. doi: 10.3969/j.issn.1673-5374.2013.05.007.

5.

Variation in Variables that Predict Progression from MCI to AD Dementia over Duration of Follow-up.

Li S, Okonkwo O, Albert M, Wang MC.

Am J Alzheimers Dis (Columbia). 2013;2(1):12-28.

6.

Pre-clinical cognitive phenotypes for Alzheimer disease: a latent profile approach.

Hayden KM, Kuchibhatla M, Romero HR, Plassman BL, Burke JR, Browndyke JN, Welsh-Bohmer KA.

Am J Geriatr Psychiatry. 2014 Nov;22(11):1364-74. doi: 10.1016/j.jagp.2013.07.008. Epub 2013 Sep 27.

7.

Dementia in Down's syndrome: an MRI comparison with Alzheimer's disease in the general population.

Mullins D, Daly E, Simmons A, Beacher F, Foy CM, Lovestone S, Hallahan B, Murphy KC, Murphy DG.

J Neurodev Disord. 2013 Aug 20;5(1):19. doi: 10.1186/1866-1955-5-19.

8.

Ventricular enlargement and its clinical correlates in the imaging cohort from the ADCS MCI donepezil/vitamin E study.

Apostolova LG, Babakchanian S, Hwang KS, Green AE, Zlatev D, Chou YY, DeCarli C, Jack CR Jr, Petersen RC, Aisen PS, Cummings JL, Toga AW, Thompson PM.

Alzheimer Dis Assoc Disord. 2013 Apr-Jun;27(2):174-81. doi: 10.1097/WAD.0b013e3182677b3d.

9.

Association of parental stroke with brain injury and cognitive measures in offspring: the Framingham Heart Study.

Weinstein G, Beiser AS, Au R, Decarli C, Wolf PA, Seshadri S.

Stroke. 2013 Mar;44(3):812-5. doi: 10.1161/STROKEAHA.112.680520. Epub 2013 Jan 29.

10.

Measuring clinical progression in MCI and pre-MCI populations: enrichment and optimizing clinical outcomes over time.

Hendrix SB.

Alzheimers Res Ther. 2012 Jul 13;4(4):24. doi: 10.1186/alzrt127. eCollection 2012. Review.

11.

The value of hippocampal and temporal horn volumes and rates of change in predicting future conversion to AD.

Macdonald KE, Bartlett JW, Leung KK, Ourselin S, Barnes J; ADNI investigators.

Alzheimer Dis Assoc Disord. 2013 Apr-Jun;27(2):168-73. doi: 10.1097/WAD.0b013e318260a79a.

12.

Recent advances in imaging Alzheimer's disease.

Braskie MN, Toga AW, Thompson PM.

J Alzheimers Dis. 2013;33 Suppl 1:S313-27. doi: 10.3233/JAD-2012-129016. Review.

13.

Selected findings from the Religious Orders Study and Rush Memory and Aging Project.

Bennett DA, Wilson RS, Arvanitakis Z, Boyle PA, de Toledo-Morrell L, Schneider JA.

J Alzheimers Dis. 2013;33 Suppl 1:S397-403. doi: 10.3233/JAD-2012-129007. Review.

14.

A two-year follow-up of cognitive deficits and brain perfusion in mild cognitive impairment and mild Alzheimer's disease.

Alegret M, Cuberas-Borrós G, Vinyes-Junqué G, Espinosa A, Valero S, Hernández I, Roca I, Ruíz A, Rosende-Roca M, Mauleón A, Becker JT, Castell-Conesa J, Tárraga L, Boada M.

J Alzheimers Dis. 2012;30(1):109-20. doi: 10.3233/JAD-2012-111850.

15.

Alliance for aging research AD biomarkers work group: structural MRI.

Jack CR Jr.

Neurobiol Aging. 2011 Dec;32 Suppl 1:S48-57. doi: 10.1016/j.neurobiolaging.2011.09.011. Review.

16.

A new model using routinely available clinical parameters to predict significant liver fibrosis in chronic hepatitis B.

Seto WK, Lee CF, Lai CL, Ip PP, Fong DY, Fung J, Wong DK, Yuen MF.

PLoS One. 2011;6(8):e23077. doi: 10.1371/journal.pone.0023077. Epub 2011 Aug 11.

17.

Steps to standardization and validation of hippocampal volumetry as a biomarker in clinical trials and diagnostic criterion for Alzheimer's disease.

Jack CR Jr, Barkhof F, Bernstein MA, Cantillon M, Cole PE, Decarli C, Dubois B, Duchesne S, Fox NC, Frisoni GB, Hampel H, Hill DL, Johnson K, Mangin JF, Scheltens P, Schwarz AJ, Sperling R, Suhy J, Thompson PM, Weiner M, Foster NL.

Alzheimers Dement. 2011 Jul;7(4):474-485.e4. doi: 10.1016/j.jalz.2011.04.007.

18.

Neuroimaging measures as endophenotypes in Alzheimer's disease.

Braskie MN, Ringman JM, Thompson PM.

Int J Alzheimers Dis. 2011 Mar 31;2011:490140. doi: 10.4061/2011/490140.

19.

Characterizing Alzheimer's disease using a hypometabolic convergence index.

Chen K, Ayutyanont N, Langbaum JB, Fleisher AS, Reschke C, Lee W, Liu X, Bandy D, Alexander GE, Thompson PM, Shaw L, Trojanowski JQ, Jack CR Jr, Landau SM, Foster NL, Harvey DJ, Weiner MW, Koeppe RA, Jagust WJ, Reiman EM; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2011 May 1;56(1):52-60. doi: 10.1016/j.neuroimage.2011.01.049. Epub 2011 Jan 27.

20.

Prediction of conversion from mild cognitive impairment to Alzheimer's disease dementia based upon biomarkers and neuropsychological test performance.

Ewers M, Walsh C, Trojanowski JQ, Shaw LM, Petersen RC, Jack CR Jr, Feldman HH, Bokde AL, Alexander GE, Scheltens P, Vellas B, Dubois B, Weiner M, Hampel H; North American Alzheimer's Disease Neuroimaging Initiative (ADNI).

Neurobiol Aging. 2012 Jul;33(7):1203-14. doi: 10.1016/j.neurobiolaging.2010.10.019. Epub 2010 Dec 14.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk